NP / PA
Harvey, Jacob
Harvey, Jacob was paid $410K by Medicaid between Jan 2018 and Jun 2022, across 12 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 48% of everything it billed.
33Billing provider infoHARVEY, JACOB
LOUISVILLE, KY 40203
LOUISVILLE, KY 40203
33aNPI1003122201assigned 08/25/2010
33bProvider typeFamily Nurse Practitioner
28Total paid$410K
24GClaims7,610
24DCodes billed12
24AFirst – last monthJan 2018 – Jun 2022
Compared with peers
Next to other Family Nurse Practitioner providers in Kentucky
Rank by total paid#52 of 424
Median peer was paid$19K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,403 | $145K | |
| 2019 | 2,130 | $123K | |
| 2020 | 1,389 | $72K | |
| 2021 | 1,159 | $48K | |
| 2022 | 529 | $22K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 48% | 3,911 | 3,685 | $196K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 39% | 1,389 | 1,291 | $162K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 7.5% | 975 | 941 | $31K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.6% | 294 | 284 | $11K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 1.1% | 69 | 69 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 108 | 53 | $2K |
| 82962 | <1% | 631 | 608 | $2K | |
| 80061 | Lipid panel | <1% | 71 | 70 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 83 | 82 | $962.79 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 49 | 47 | $709.97 |
| 81003 | <1% | 15 | 15 | $38.78 | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | 0% | 15 | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.